[
    [
        {
            "time": "2023-11-01",
            "orginal_text": "【太平洋策略-流动性周报】外资流入超200亿，买入科技和消费",
            "features": {
                "keywords": [
                    "外资流入",
                    "科技",
                    "消费"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "科技",
                    "消费"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "【太平洋策略-流动性周报】外资流入超200亿，买入科技和消费",
            "scores": {
                "News_content": "【太平洋策略-流动性周报】外资流入超200亿，买入科技和消费",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2023-11-01",
            "orginal_text": "医保谈判：四大焦点在这里",
            "features": {
                "keywords": [
                    "医保谈判",
                    "焦点"
                ],
                "sentiment_score": 0.6,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "医保谈判：四大焦点在这里",
            "scores": {
                "News_content": "医保谈判：四大焦点在这里",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-11-01",
            "orginal_text": "不选择license in，看璎黎药业的从0到1之路",
            "features": {
                "keywords": [
                    "license in",
                    "璎黎药业",
                    "创新药"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "original_text": "不选择license in，看璎黎药业的从0到1之路",
            "scores": {
                "News_content": "不选择license in，看璎黎药业的从0到1之路",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2023-11-01",
            "orginal_text": "粤开策略：回测十年寻规律，跨年行情或开启",
            "features": {
                "keywords": [
                    "跨年行情",
                    "回测",
                    "规律"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "综合"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "粤开策略：回测十年寻规律，跨年行情或开启",
            "scores": {
                "News_content": "粤开策略：回测十年寻规律，跨年行情或开启",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-11-01",
            "orginal_text": "2020医保谈判进入倒计时 药企又要“血拼”了？",
            "features": {
                "keywords": [
                    "医保谈判",
                    "药企",
                    "血拼"
                ],
                "sentiment_score": 0.4,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "original_text": "2020医保谈判进入倒计时 药企又要“血拼”了？",
            "scores": {
                "News_content": "2020医保谈判进入倒计时 药企又要“血拼”了？",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 6,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        },
        {
            "time": "2023-11-01",
            "orginal_text": "2021年医药生物行业策略报告：聚焦黄金赛道 寻找疫后高光",
            "features": {
                "keywords": [
                    "医药生物",
                    "黄金赛道",
                    "疫后高光"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "original_text": "2021年医药生物行业策略报告：聚焦黄金赛道 寻找疫后高光",
            "scores": {
                "News_content": "2021年医药生物行业策略报告：聚焦黄金赛道 寻找疫后高光",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        }
    ]
]